Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Renalytix AI (RNLX) has shared an announcement.
Renalytix plc issued convertible bonds worth $21.2 million in April 2022, attracting interest at 5.5% annually, with the possibility of repaying in cash or shares. Starting July 2022, they began repaying in equal quarterly installments. By April 2024, they plan to issue over 3.6 million shares to settle a portion of the debt, reducing the principal by $1.06 million. The company has announced this repayment through a press release, clarifying that the announcement is not considered legally filed but is for informational purposes only.
For a thorough assessment of RNLX stock, go to TipRanks’ Stock Analysis page.